Study of AnnexinA3 and Platelet Derived Endothelial Cell Growth Factor (Thymidine Phosphorylase) in Colorectal cancer

Ahmad, Nagwa Sayed; Genedy, Amera; Zakhary, Madeha; Ftohy, Tarek

doi:10.21608/smj.2017.41069

Study of AnnexinA3 and Platelet Derived Endothelial Cell Growth Factor (Thymidine Phosphorylase) in Colorectal cancer

Document Type : Original Article

Authors

¹ Debartment of Biochemistry, Faculty of Medicine, Sohag University.

² Debartment of Biochemistry, Faculty of Medicine, Assuit University.

³ General Surgery Faculty of Medicine , Sohag university.

10.21608/smj.2017.41069

Abstract

Background:Colorectal cancer (CRC) is a common malignant tumor of the gastrointestinal tract, constituting 10% of new colorectal cancer cases each year. Despite major breakthroughs in the treatment of colorectal cancer, 40–50% of patients are likely to develop local or distant tumor recurrences, and survival rates are poor.
Aim of the workis to evaluate the levels of annexin A3 and thymidine phosphorylase in patients with colorectal cancer and compare these levels with control persons and to ascertain whether annexin A3 and thymidine phosphorylase are involved in the progression of the colorectal cancer and their impact on patient outcome.
Patients and methods: This study was performed at Sohag University Hospital from December 2015 to December 2016 , Seventy five patients were enrolled in the study and divided into two groups. 60 patients with colorectal cancer, 15 patients with benign colorectal disease. All were matched for age and sex, for each participant body mass index (BMI), blood pressure, Annexin A3 by Eliza kit , Thymidine phosphorylase by colorimetric method were performed.
Results:There were significant relations between Annexin A3and Thymidine phosphorylase and age.Significant relations were observed between Annexin A3and Thymidine phosphorylase and type of cancer.Strong positive correlation was observed between Annexin A3and Thymidine phosphorylase.
Conculsion :we conclude that both of Annexin A3 and Thymidine phosphorylase were positive correlated with type and grade of colorectal cancer .So using Annexin A3 and thymidine phosphorylase as positive biomarker in the progression of colorectal cancer may be beneficial.

Keywords

References

1-Ferlay J,SoerjomataramI,DikshitR,et al:(2015);Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.Int J cancer2015;136:E359-86.

2-Stryker SJ,WolffBG,CulpCE,LibbeSD, IlstrupDM,Mac Carty RL: (1987);Natural history of un treated colonic polyps.Gastro enteral 92:1009-13

3- O′Connell JB,MaggardM,koCY: (2004),colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging.JNCI96:1420-5

4-Gerke V, Creutz CE, Moss SE: (2005); Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6:449–461

5-Zimmermann U, Woenckhaus C, Teller S, et al: (2007);Expression of annexin AI in conventional renal cell carcinoma (CRCC) correlates with tumour stage, Fuhrman grade, amount of eosinophilic cells and clinical outcome. HistolHistopathol 2007;22(5):527-34.

6-Chen R, Brentnall TA, Pan S, et al: (2007);Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics. 6:1331–1342.

7-Köllermann J, Schlomm T, Bang H, et al:( 2008);Expression and prognostic relevance of Annexin A3 in prostate cancer. Eur Urol. 54:1314–1323

8- Yan X, Yin J, Yao H, Mao N, Yang Y and Pan L: (2010);Increased expression of Annexin A3 is a mechanism of platinum resistance in ovarian cancer. Cancer Res 70: 1616‑1624

9-BartelDn P:(2009);"Micro RNAᴤ:Target recognition and regulatory functions".Cell 136(2):215-33

10-Tan Y, Meng HP, Teng FM, et al: (2010: Effect of miRNA interference to AnnexinA3 gene on growth of human gallbladder cancer cells. Chin HepatobiliarySurg16:853–856

11-Bronckaers A, Gago F, Balzarini J, Liekens S :(2009) ;The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med Res Rev 29(6):903–953

12-Furukawa,T.,Ikeda,R.,Haraguchi,M. andAkiyama,S:2001);Thymidinephosphorylase, a new molecular target for anti cancer therapy.Curr. Top. .Res.489-95.

13-Shimaoka S,MatsushitaS,NitandaT,MatsudaA,NiohT,SuenagaT,NishimataY,AkibaS,Akiyama S and Nishimata H: (2000),The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma.Cancer882220-2227.

14-Koopman M,VenderboschS,NagtegaalID,VanKriekenJ.H.and Punt C.J: (2009),Are view on the use of molecular markers of cytotoxic therapy for colorectal cancer,what have we learned?.Eur J Cancer,45 11178-212.

15-Amatori F, Di Paolo A, Del Tacca M, Fontanini G, Vannozzi F, Boldrini L, Bocci G, Lastella M, Danesi R: (2006);Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa inpatients. Pharmacogenet Genomics16:809-816.

16- Matsuura T, Kuratate I, Teramachi K, Osaki M, Fukuda Y, ItoH: (1999), Thymidine phosphorylase expression is associated with both increase of intra tumoral micro vessels and decrease of apoptosis in human colorectal carcinomas.Cancer Res 59:5037-5040.

17-Nozawa T, Enomoto T, Koshida Y, Sato Y, Kuranami M: (2004), Specific enhanced expression of platelet-derived endothelial cell growth factor in sub mucosa of human colorectal cancer. Dis Colon Rectum 47:2093-2100.

18- Center MM, Jemal A, Smith RA, Ward E:(2009); Worldwide varia -tions in colorectal cancer. CA Cancer J Clin;59:366–78.

19-World Health Organization Mortality Databases,(2009); World Health Organization.

20-Na Wu,Shuqing Liu;ChunmeiGuo;ZhijieHou; Ming-Zhong Sun:(2013);The role of annexin A3 playing in cancers, ClinTranslOncol ,15:106–110.

21-Yip KT, Das PK, Suria D, Lim CR, Ng GH, Liew CC :(2010); A case-controlled validation study of a blood based seven gene biomarker panel for colorectal cancer in Malaysia. J ExpClin Cancer Res 29:128

22-YONG -QIU XIE, DI FU, ZHENG-HUA HE and QING -DONG TAN:(2013); World jounaly of clinical cases,Oncology Letters 6: 1631-1635

23-Michiya Kobayashi, Ken Okamoto, ToyokazuAkimori, NaoshigeTochika, Tadashi Yoshimoto, TakehiroOkabayashi, Takeki Sugimoto , Keijiro Araki:(2004);Localization of Thymidine Phosphorylase in Advanced Gastric and Colorectal Cancer,Journal of Molecular Histology 35: 69–74.

24-Haraguchi M, Komuta K, Ueda T, Akashi A, Minami S, Furui J, Kanematsu T:(2008);Prognostic significance of the serum thymidine phosphorylase levels in venous blood drainage specimens in patients with colorectal cancer, Hepato-gastroentrology,55(82-83):418-421.

25-Sengupta S, Sellers LA, Matheson HB, Fan TP:( 2003); Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br J Pharmacol, 139:219–231.

26-Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, Miyadera K, Yamada Y, Aikou T, Akiyama S:( 1998); Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. BiochemBiophys Res Commun, 253:797–803.

27-Mimori K, Matsuyama A, Yoshinaga K, Yamashita K, Masuda T, Inoue H, Ueo H, Mori M:( 2002); Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay. Oncology, 62:327–332.